The EMCDDA evaluate the CTC approach, which sets out to reduce adolescent health and behavioural problems by identifying strong risk factors and weak protective factors, and selecting prevention and early intervention programmes to address them.
The Regional Harm Reduction Conference will be dedicated to the results, lessons learnt, and perspectives of civil society and community-driven advocacy for sustainable and high-quality harm reduction programs in CEECA.
The results of an EMCDDA study on national drug trafficking laws and their application in the European Union. The penalties set out in national laws for trafficking are compared with the expected sentencing outcomes, including the estimated time to be spent in prison.
This study aims to provide evidence on international and EU approaches to drug policy, including emerging challenges and focusing on several case study countries. This evidence has been used to identify and develop policy proposals.
The EECA statement argues that the currently alarming epidemiologic situation and an envisioned decrease in funding, might affect the sustainability of the positive results worldwide in combating AIDS, and less effective implementation of the new global target: to end HIV by 2030.
The EMCDDA met to discuss how the Council conclusions on the implementation of minimum quality standards in drug demand reduction in the EU can relate to projects at national, European and international level.
The International Conference on Medical Cannabis, held at the EU Parliament, aimed share knowledge about the state of legislation around the world today, and to educate regulators present about the importance of building legal, regulated cannabis markets in Europe.